Though it happened some times ago, the TRIM clinical trial was really a real small scale research.
According to the following info:
http://interveneimmune.com/?ignition_product=the-triim-trialhttp://interveneimmune.com/?page_id=1200
This company is found by Greg Fahy, PhD, Chief Scientific Officer, Co-founder
-Published the first report of thymus regeneration in a normal human; Granted patents on methods for and applications of human thymus regeneration
–Fellow of the American Aging Association (since 2005), Former Director of the American Aging Association (16 years)
–Editor-in-Chief, The Future of Aging: Pathways to Human Life Extension
–Awarded the Society for Cryobiology’s Luyet Medal in 2016
–In 2009, showed indefinite survival of rabbit kidney transplanted after cooling to -130° Celsius; Led 21CM team as co-winner of Small Mammal Brain Preservation Prize, 2018 winner of Large Mammal Brain Preservation Prize
and
Steve Horvath, PhD, Scientific Collaborator
-Professor of Human Genetics & Biostatistics at UCLA
-Developer of the DNA methylation clock of human aging, as well as author of seminal papers demonstrating ability to accurately predict life expectancy, onset of Alzheimer's, cognitive decline, and more
-Paul G. Allen Distinguished Investigator
-Ph.D. Mathematics at UNC, Sc.D. Biostatistics from Harvard University